TEAD2 as a novel prognostic factor for hepatocellular carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• TEA Domain Transcription Factors (TEADs) play roles in development and cancer.
• The specific role of TEAD2 in hepatocellular carcinoma (HCC) remains underexplored.

Purpose of the Study:

• To investigate TEAD2 expression in HCC.
• To determine if TEAD2 expression correlates with HCC patient prognosis.

Main Methods:

• Utilized The Cancer Genome Atlas (TCGA) database for HCC and normal samples.
• Performed gene expression analysis, GeneNeighbors, ClassNeighbors, and survival analyses.
• Conducted Gene Set Enrichment Analysis (GSEA) to explore pathway associations.

Main Results:

• TEAD2 and VGLL4 mRNA expression were elevated in HCC compared to normal tissues.
• Higher TEAD2 expression correlated with advanced HCC stages.
• Increased TEAD2 mRNA expression was significantly associated with poorer overall survival in HCC patients (P=0.0067).
• Elevated TEAD2 and VGLL4 expression linked to enhanced epithelial-mesenchymal transition and angiogenesis.

Conclusions:

• Elevated TEAD2 mRNA expression indicates a poor prognosis in HCC.
• TEAD2 shows potential as a prognostic biomarker for HCC.
• TEAD2 represents a possible novel therapeutic target for HCC treatment.